Shan Lei

983 total citations
46 papers, 665 citations indexed

About

Shan Lei is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shan Lei has authored 46 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 27 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shan Lei's work include MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (11 papers) and RNA modifications and cancer (10 papers). Shan Lei is often cited by papers focused on MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (11 papers) and RNA modifications and cancer (10 papers). Shan Lei collaborates with scholars based in China, United States and Australia. Shan Lei's co-authors include Zhirui Zeng, Wenpeng Cao, Zhiwei He, Tengxiang Chen, Jianxin Jiang, David Yang, Dapeng Wang, Peng Tian, Qianqian Li and Xingjun Guo and has published in prestigious journals such as Molecules, Frontiers in Microbiology and Journal of Cellular Physiology.

In The Last Decade

Shan Lei

45 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shan Lei China 14 448 348 107 92 73 46 665
Ruting Xie China 18 499 1.1× 263 0.8× 79 0.7× 197 2.1× 66 0.9× 38 778
Farah Nassar Lebanon 18 642 1.4× 455 1.3× 78 0.7× 205 2.2× 104 1.4× 35 1.0k
Jianhua Zhou China 18 533 1.2× 256 0.7× 91 0.9× 136 1.5× 25 0.3× 52 792
Kunning Wang China 6 718 1.6× 249 0.7× 91 0.9× 264 2.9× 76 1.0× 8 891
Xueliang Zhang China 15 363 0.8× 239 0.7× 61 0.6× 84 0.9× 19 0.3× 27 605
Xiaohui Wei China 14 366 0.8× 208 0.6× 76 0.7× 135 1.5× 62 0.8× 41 716
Araceli Valverde United States 12 216 0.5× 181 0.5× 52 0.5× 90 1.0× 29 0.4× 28 534
Wenna Shi China 13 385 0.9× 294 0.8× 37 0.3× 94 1.0× 101 1.4× 23 693

Countries citing papers authored by Shan Lei

Since Specialization
Citations

This map shows the geographic impact of Shan Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Lei more than expected).

Fields of papers citing papers by Shan Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Lei. The network helps show where Shan Lei may publish in the future.

Co-authorship network of co-authors of Shan Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Shan Lei. A scholar is included among the top collaborators of Shan Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Lei. Shan Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Wenpeng, Shipeng Luo, Baofei Sun, et al.. (2024). FOXP3 promote the progression of glioblastoma via inhibiting ferroptosis mediated by linc00857/miR-1290/GPX4 axis. Cell Death and Disease. 15(4). 239–239. 10 indexed citations
2.
Lei, Shan, et al.. (2024). Cynaroside Induces G1 Cell Cycle Arrest by Downregulating Cell Division Cycle 25A in Colorectal Cancer. Molecules. 29(7). 1508–1508. 4 indexed citations
3.
Li, Dahuan, et al.. (2024). Identification of Clinical Value and Biological Effects of XIRP2 Mutation in Hepatocellular Carcinoma. Biology. 13(8). 633–633. 2 indexed citations
4.
Cao, Wenpeng, et al.. (2024). Exosome-derived circ-001422 promotes tumor-associated macrophage M2 polarization to accelerate the progression of glioma. Communications Biology. 7(1). 1504–1504. 7 indexed citations
5.
Cao, Wenpeng, et al.. (2023). Ar-turmerone inhibits the proliferation and mobility of glioma by downregulating cathepsin B. Aging. 15(18). 9377–9390. 5 indexed citations
6.
Chen, Tengxiang, et al.. (2023). [Oenothein B inhibits proliferation and migration of breast cancer cells by regulating P53].. PubMed. 48(14). 3904–3912. 1 indexed citations
7.
Cao, Wenpeng, et al.. (2023). Gastrodin Induces Ferroptosis of Glioma Cells via Upregulation of Homeobox D10. Molecules. 28(24). 8062–8062. 10 indexed citations
8.
Zeng, Zhirui, Lian Li, Shan Lei, et al.. (2023). Sinapine thiocyanate exhibited anti-colorectal cancer effects by inhibiting KRT6A/S100A2 axis. Cancer Biology & Therapy. 24(1). 2249170–2249170. 5 indexed citations
9.
Cao, Wenpeng, et al.. (2023). Terpinen-4-ol Induces Ferroptosis of Glioma Cells via Downregulating JUN Proto-Oncogene. Molecules. 28(12). 4643–4643. 12 indexed citations
10.
Cao, Wenpeng, Zhirui Zeng, & Shan Lei. (2023). 5′-tRF-19-Q1Q89PJZ Suppresses the Proliferation and Metastasis of Pancreatic Cancer Cells via Regulating Hexokinase 1-Mediated Glycolysis. Biomolecules. 13(10). 1513–1513. 6 indexed citations
11.
Zhang, Lu, et al.. (2023). An inflammation‐associated ferroptosis signature optimizes the diagnosis, prognosis evaluation and immunotherapy options in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. 27(13). 1820–1835. 9 indexed citations
12.
Cao, Wenpeng, et al.. (2023). Pancreatic stellate cell‐derived exosomal tRF‐19‐PNR8YPJZ promotes proliferation and mobility of pancreatic cancer through AXIN2. Journal of Cellular and Molecular Medicine. 27(17). 2533–2546. 18 indexed citations
13.
Lei, Shan, Wenpeng Cao, Zhirui Zeng, et al.. (2022). JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis. Cell Death and Disease. 13(11). 967–967. 38 indexed citations
14.
Chen, Peng, et al.. (2022). Long noncoding RNA LINC00857 promotes pancreatic cancer proliferation and metastasis by regulating the miR-130b/RHOA axis. Cell Death Discovery. 8(1). 198–198. 13 indexed citations
15.
Wang, Jingya, Zhirui Zeng, Shan Lei, et al.. (2022). Sinapine Thiocyanate Inhibits the Proliferation and Mobility of Pancreatic Cancer Cells by Up-Regulating GADD45A. Journal of Cancer. 13(4). 1229–1240. 9 indexed citations
16.
He, Zhiwei, Kun Cai, Zhirui Zeng, et al.. (2022). Autophagy-associated circRNA circATG7 facilitates autophagy and promotes pancreatic cancer progression. Cell Death and Disease. 13(3). 233–233. 50 indexed citations
17.
Wu, Jiajing, Shan Lei, Qiang Liu, et al.. (2021). Clofazimine: A Promising Inhibitor of Rabies Virus. Frontiers in Pharmacology. 12. 598241–598241. 10 indexed citations
18.
Zeng, Zhirui, et al.. (2020). <p>Simultaneous Inhibition of Ornithine Decarboxylase 1 and Pyruvate Kinase M2 Exerts Synergistic Effects Against Hepatocellular Carcinoma Cells</p>. OncoTargets and Therapy. Volume 13. 11697–11709. 11 indexed citations
19.
Lei, Shan, Weijin Huang, Youchun Wang, & Qiang Liu. (2019). In Vivo Bioluminescent Imaging of Marburg Virus in a Rodent Model. Methods in molecular biology. 2081. 177–190. 4 indexed citations
20.
Lei, Shan, Zhiwei He, Tengxiang Chen, et al.. (2019). Long noncoding RNA 00976 promotes pancreatic cancer progression through OTUD7B by sponging miR-137 involving EGFR/MAPK pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 470–470. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026